2024 Q3 Form 10-Q Financial Statement

#000121465924014333 Filed on August 13, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $5.435M $5.352M
YoY Change -3.02% 0.32%
Cost Of Revenue $3.540M $3.262M
YoY Change 6.88% -7.2%
Gross Profit $1.895M $2.090M
YoY Change -17.32% 14.84%
Gross Profit Margin 34.87% 39.05%
Selling, General & Admin $1.179M $1.104M
YoY Change -62.48% -61.24%
% of Gross Profit 62.22% 52.82%
Research & Development $5.000K $5.000K
YoY Change 0.0% -50.0%
% of Gross Profit 0.26% 0.24%
Depreciation & Amortization $300.0K
YoY Change 16.28%
% of Gross Profit 14.35%
Operating Expenses $4.765M $2.626M
YoY Change 51.41% -8.12%
Operating Profit -$2.870M -$536.0K
YoY Change 235.67% -48.36%
Interest Expense -$42.00K
YoY Change 162.5%
% of Operating Profit
Other Income/Expense, Net $446.0K $190.0K
YoY Change -694.67% 21.79%
Pretax Income -$346.0K
YoY Change -60.77%
Income Tax
% Of Pretax Income
Net Earnings -$2.424M -$346.0K
YoY Change 160.65% -60.77%
Net Earnings / Revenue -44.6% -6.46%
Basic Earnings Per Share -$0.23 -$0.03
Diluted Earnings Per Share -$0.23 -$0.03
COMMON SHARES
Basic Shares Outstanding 10.38M shares 10.18M shares
Diluted Shares Outstanding 10.60M shares 10.24M shares

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.900M
YoY Change 7.53%
Cash & Equivalents $2.610M $2.900M
Short-Term Investments
Other Short-Term Assets $210.0K
YoY Change -31.82%
Inventory $19.00K $23.00K
Prepaid Expenses
Receivables $1.200M $1.214M
Other Receivables $0.00
Total Short-Term Assets $4.820M $5.098M
YoY Change -14.16% 0.51%
LONG-TERM ASSETS
Property, Plant & Equipment $159.0K $184.0K
YoY Change -40.0% -36.11%
Goodwill $3.988M $5.334M
YoY Change -24.94% -0.07%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $10.01M $12.44M
YoY Change -24.12% -6.87%
TOTAL ASSETS
Total Short-Term Assets $4.820M $5.098M
Total Long-Term Assets $10.01M $12.44M
Total Assets $14.83M $17.53M
YoY Change -21.15% -4.84%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.622M $1.331M
YoY Change 8.35% -4.93%
Accrued Expenses $455.0K $808.0K
YoY Change -44.17% 11.76%
Deferred Revenue
YoY Change
Short-Term Debt $500.0K $500.0K
YoY Change 0.0% 0.0%
Long-Term Debt Due $500.0K
YoY Change -61.54%
Total Short-Term Liabilities $2.765M $2.927M
YoY Change -23.91% -21.3%
LONG-TERM LIABILITIES
Long-Term Debt $1.725M
YoY Change 53.33%
Other Long-Term Liabilities $624.0K
YoY Change -48.94%
Total Long-Term Liabilities $2.349M
YoY Change 0.09%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.765M $2.927M
Total Long-Term Liabilities $2.349M
Total Liabilities $4.549M $5.276M
YoY Change -34.14% -13.02%
SHAREHOLDERS EQUITY
Retained Earnings -$85.17M -$82.75M
YoY Change 4.06% 2.26%
Common Stock $11.00K $11.00K
YoY Change 10.0% 10.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $464.0K $464.0K
YoY Change -37.97% -41.41%
Treasury Stock Shares
Shareholders Equity $10.28M $12.26M
YoY Change
Total Liabilities & Shareholders Equity $14.83M $17.53M
YoY Change -21.15% -4.84%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income -$2.424M -$346.0K
YoY Change 160.65% -60.77%
Depreciation, Depletion And Amortization $300.0K
YoY Change 16.28%
Cash From Operating Activities $372.0K
YoY Change -210.39%
INVESTING ACTIVITIES
Capital Expenditures $81.00K
YoY Change -62.67%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$81.00K
YoY Change -65.82%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -207.0K
YoY Change -211.89%
NET CHANGE
Cash From Operating Activities 372.0K
Cash From Investing Activities -81.00K
Cash From Financing Activities -207.0K
Net Change In Cash 84.00K
YoY Change -121.59%
FREE CASH FLOW
Cash From Operating Activities $372.0K
Capital Expenditures $81.00K
Free Cash Flow $291.0K
YoY Change -152.53%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
210000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
usd
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
2624000 usd
CY2024Q2 us-gaap Cost Of Revenue
CostOfRevenue
3262000 usd
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
3749000 usd
CY2024Q2 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
usd
CY2024Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
usd
vrme Deferred Implementation Costs
DeferredImplementationCosts
usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
usd
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
shares
vrme Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures And Expirations
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations
shares
vrme Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriodWeightedAverageExercisePrice
CY2024Q2 vrme Sharebased Compensation Arrangement By Sharebased Payment Award Other Than Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOtherThanOptionsExercisableIntrinsicValue1
usd
CY2024Q2 vrme Rightofuse Assets Obtained In Exchange For Operating Lease Liabilities
RightofuseAssetsObtainedInExchangeForOperatingLeaseLiabilities
usd
CY2023Q4 vrme Rightofuse Assets Obtained In Exchange For Operating Lease Liabilities
RightofuseAssetsObtainedInExchangeForOperatingLeaseLiabilities
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-39332
dei Entity Registrant Name
EntityRegistrantName
VERIFYME, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
23-3023677
dei Entity Address Address Line1
EntityAddressAddressLine1
801 International Parkway
dei Entity Address Address Line2
EntityAddressAddressLine2
Fifth Floor
dei Entity Address City Or Town
EntityAddressCityOrTown
Lake Mary
dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
32746
dei City Area Code
CityAreaCode
(585)
dei Local Phone Number
LocalPhoneNumber
736-9400
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
10384698 shares
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2900000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3095000 usd
CY2024Q2 us-gaap Accounts And Financing Receivable Allowance For Credit Loss
AccountsAndFinancingReceivableAllowanceForCreditLoss
156000 usd
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1214000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3017000 usd
CY2024Q2 vrme Unbilled Revenue
UnbilledRevenue
751000 usd
CY2023Q4 vrme Unbilled Revenue
UnbilledRevenue
1282000 usd
CY2024Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
210000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
254000 usd
CY2024Q2 us-gaap Inventory Net
InventoryNet
23000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
38000 usd
CY2024Q2 us-gaap Assets Current
AssetsCurrent
5098000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
7686000 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
184000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
240000 usd
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
378000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
468000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
6539000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
6927000 usd
CY2024Q2 us-gaap Goodwill
Goodwill
5334000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
5384000 usd
CY2024Q2 us-gaap Assets
Assets
17533000 usd
CY2023Q4 us-gaap Assets
Assets
20705000 usd
CY2024Q2 us-gaap Debt Current
DebtCurrent
500000 usd
CY2023Q4 us-gaap Debt Current
DebtCurrent
500000 usd
CY2024Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1331000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3310000 usd
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
808000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
988000 usd
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
165000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
170000 usd
CY2024Q2 vrme Contingent Liability Current
ContingentLiabilityCurrent
123000 usd
CY2023Q4 vrme Contingent Liability Current
ContingentLiabilityCurrent
173000 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
2927000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5141000 usd
CY2024Q2 vrme Contingent Liability Non Current
ContingentLiabilityNonCurrent
401000 usd
CY2023Q4 vrme Contingent Liability Non Current
ContingentLiabilityNonCurrent
751000 usd
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
223000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
307000 usd
CY2024Q2 vrme Term Note
TermNote
625000 usd
CY2023Q4 vrme Term Note
TermNote
875000 usd
CY2024Q2 vrme Convertible Note Related Party
ConvertibleNoteRelatedParty
475000 usd
CY2023Q4 vrme Convertible Note Related Party
ConvertibleNoteRelatedParty
475000 usd
CY2024Q2 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
625000 usd
CY2023Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
625000 usd
CY2024Q2 us-gaap Liabilities
Liabilities
5276000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
8174000 usd
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
675000000 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10655065 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10384698 shares
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
11000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
10000 usd
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
95504000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
95031000 usd
CY2024Q2 vrme Treasury Stock Share
TreasuryStockShare
270367 shares
CY2024Q2 us-gaap Treasury Stock Value
TreasuryStockValue
464000 usd
CY2023Q4 us-gaap Treasury Stock Value
TreasuryStockValue
659000 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-82748000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-81849000 usd
CY2024Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-46000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
12257000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
12531000 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
17533000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
20705000 usd
CY2024Q2 us-gaap Revenues
Revenues
5352000 usd
CY2023Q2 us-gaap Revenues
Revenues
5335000 usd
CY2024Q2 us-gaap Gross Profit
GrossProfit
2090000 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
1586000 usd
CY2024Q2 us-gaap Management Fee Expense
ManagementFeeExpense
1517000 usd
CY2023Q2 us-gaap Management Fee Expense
ManagementFeeExpense
1251000 usd
CY2024Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
894000 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
836000 usd
CY2024Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5000 usd
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10000 usd
CY2023Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
527000 usd
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
2626000 usd
us-gaap Operating Expenses
OperatingExpenses
5533000 usd
us-gaap Operating Expenses
OperatingExpenses
5649000 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-536000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1038000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1183000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-2542000 usd
CY2024Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-42000 usd
CY2023Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-46000 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-80000 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-88000 usd
CY2023Q2 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
30000 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-2000 usd
CY2024Q2 us-gaap Asset Acquisition Consideration Transferred Contingent Consideration
AssetAcquisitionConsiderationTransferredContingentConsideration
232000 usd
CY2023Q2 us-gaap Asset Acquisition Consideration Transferred Contingent Consideration
AssetAcquisitionConsiderationTransferredContingentConsideration
172000 usd
us-gaap Asset Acquisition Consideration Transferred Contingent Consideration
AssetAcquisitionConsiderationTransferredContingentConsideration
364000 usd
us-gaap Asset Acquisition Consideration Transferred Contingent Consideration
AssetAcquisitionConsiderationTransferredContingentConsideration
172000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2000 usd
CY2024Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
190000 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
156000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
284000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
80000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-346000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-882000 usd
us-gaap Net Income Loss
NetIncomeLoss
-899000 usd
us-gaap Net Income Loss
NetIncomeLoss
-2462000 usd
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.09
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.09
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.26
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.09
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.09
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.26
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10238717 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9765452 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10156081 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9614183 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10238717 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9765452 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10156081 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9614183 shares
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-346000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-882000 usd
us-gaap Net Income Loss
NetIncomeLoss
-899000 usd
us-gaap Net Income Loss
NetIncomeLoss
-2462000 usd
CY2024Q2 vrme Change In Fair Value Of Interest Rate Swap
ChangeInFairValueOfInterestRateSwap
2000 usd
CY2023Q2 vrme Change In Fair Value Of Interest Rate Swap
ChangeInFairValueOfInterestRateSwap
2000 usd
vrme Change In Fair Value Of Interest Rate Swap
ChangeInFairValueOfInterestRateSwap
5000 usd
vrme Change In Fair Value Of Interest Rate Swap
ChangeInFairValueOfInterestRateSwap
1000 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
-18000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
46000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
49000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
48000 usd
CY2024Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-326000 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-926000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-943000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2509000 usd
us-gaap Net Income Loss
NetIncomeLoss
-899000 usd
us-gaap Net Income Loss
NetIncomeLoss
-2462000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
9000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
4000 usd
us-gaap Dividends Sharebased Compensation Stock
DividendsSharebasedCompensationStock
89000 usd
us-gaap Dividends Sharebased Compensation Stock
DividendsSharebasedCompensationStock
41000 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-2000 usd
vrme Change In Fair Value Of Contingent Consideration
ChangeInFairValueOfContingentConsideration
364000 usd
vrme Change In Fair Value Of Contingent Consideration
ChangeInFairValueOfContingentConsideration
172000 usd
vrme Fair Value Of Restricted Stock Awards And Restricted Stock Units Issued In Exchange For Services
FairValueOfRestrictedStockAwardsAndRestrictedStockUnitsIssuedInExchangeForServices
-608000 usd
vrme Fair Value Of Restricted Stock Awards And Restricted Stock Units Issued In Exchange For Services
FairValueOfRestrictedStockAwardsAndRestrictedStockUnitsIssuedInExchangeForServices
-560000 usd
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-2000 usd
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
13000 usd
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
34000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
599000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
540000 usd
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-30000 usd
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-10000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1790000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-3156000 usd
vrme Oprating Unbilled Revenue
OpratingUnbilledRevenue
530000 usd
vrme Oprating Unbilled Revenue
OpratingUnbilledRevenue
451000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-15000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-34000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-47000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-46000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-2155000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-2709000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
312000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-463000 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
12000 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
42000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
24000 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
363000 usd
vrme Deferred Implementation Costs
DeferredImplementationCosts
56000 usd
us-gaap Payments For Software
PaymentsForSoftware
174000 usd
us-gaap Payments For Software
PaymentsForSoftware
373000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-191000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-858000 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
800000 usd
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
21000 usd
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
71000 usd
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
36000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
47000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
3000 usd
us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
1000 usd
us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
10000 usd
us-gaap Repayments Of Debt
RepaymentsOfDebt
250000 usd
us-gaap Repayments Of Debt
RepaymentsOfDebt
250000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-313000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
608000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-3000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-1000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-195000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-714000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3095000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3411000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2900000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2697000 usd
us-gaap Interest Paid Net
InterestPaidNet
94000 usd
us-gaap Interest Paid Net
InterestPaidNet
68000 usd
vrme Noncash Change In Fair Value Of Interest Rate Swap
NoncashChangeInFairValueOfInterestRateSwap
5000 usd
vrme Noncash Change In Fair Value Of Interest Rate Swap
NoncashChangeInFairValueOfInterestRateSwap
1000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
12962000 usd
CY2023Q2 vrme Restricted Stock Awards Net Of Shares Withheld For Employee Tax
RestrictedStockAwardsNetOfSharesWithheldForEmployeeTax
146000 usd
CY2023Q2 vrme Restricted Stock Units Net Of Shares Withheld For Employee Tax
RestrictedStockUnitsNetOfSharesWithheldForEmployeeTax
148000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
28000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-44000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-882000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
12358000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
12391000 usd
CY2024Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
128000 usd
CY2024Q2 vrme Restricted Stock Units Net Of Shares Withheld For Employee Tax
RestrictedStockUnitsNetOfSharesWithheldForEmployeeTax
22000 usd
CY2024Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
42000 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
20000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-346000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
12257000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
13586000 usd
vrme Restricted Stock Awards Net Of Shares Withheld For Employee Tax
RestrictedStockAwardsNetOfSharesWithheldForEmployeeTax
147000 usd
vrme Restricted Stock Units Net Of Shares Withheld For Employee Tax
RestrictedStockUnitsNetOfSharesWithheldForEmployeeTax
410000 usd
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
109000 usd
vrme Common Stock Issued In Relation To Acquisition
CommonStockIssuedInRelationToAcquisition
625000 usd
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
10000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-47000 usd
us-gaap Net Income Loss
NetIncomeLoss
-2462000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
12358000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
12531000 usd
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
276000 usd
vrme Restricted Stock Units Net Of Shares Withheld For Employee Tax
RestrictedStockUnitsNetOfSharesWithheldForEmployeeTax
285000 usd
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
25000 usd
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
84000 usd
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
1000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-44000 usd
us-gaap Net Income Loss
NetIncomeLoss
-899000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
12257000 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p id="xdx_84E_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zX6cMcSelhnj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><b><i><span style="text-decoration: underline"><span id="xdx_864_zVv3Odqx4Rff">Reclassifications</span></span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Certain amounts presented for the three and six months ended June 30, 2023, reflect reclassifications made to conform to the presentation in our current reporting period. These reclassifications had no effect on the previously reported net loss.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2900000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3032000 usd
CY2024Q2 us-gaap Restricted Cash
RestrictedCash
-0 usd
CY2023Q4 us-gaap Restricted Cash
RestrictedCash
63000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2900000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3095000 usd
CY2023Q4 us-gaap Restricted Cash
RestrictedCash
63000 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_842_eus-gaap--UseOfEstimates_zSJE4S0ekKT7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i><span style="text-decoration: underline"><span id="xdx_86B_zqO0NiKOZU44">Use of Estimates</span></span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p>
CY2024Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8208000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8208000 shares
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7108000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7108000 shares
CY2024Q2 us-gaap Revenues
Revenues
5352000 usd
CY2023Q2 us-gaap Revenues
Revenues
5335000 usd
us-gaap Revenues
Revenues
11111000 usd
us-gaap Revenues
Revenues
10996000 usd
CY2023Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
1282000 usd
CY2022Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
1185000 usd
vrme Contract Asset Additions
ContractAssetAdditions
4329000 usd
vrme Contract Asset Additions
ContractAssetAdditions
3326000 usd
vrme Reclassification To Accounts Receivable Billed To Customers
ReclassificationToAccountsReceivableBilledToCustomers
-4860000 usd
vrme Reclassification To Accounts Receivable Billed To Customers
ReclassificationToAccountsReceivableBilledToCustomers
-3777000 usd
CY2023Q2 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
734000 usd
CY2023Q1 vrme Business Combination Consideration Transferred
BusinessCombinationConsiderationTransferred
360000 usd
CY2023Q1 vrme Earnout Consideration
EarnoutConsideration
1100000 usd
CY2024Q2 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
123000 usd
CY2024Q2 vrme Business Combination Long Term Contingent Consideration
BusinessCombinationLongTermContingentConsideration
401000 usd
CY2024Q2 vrme Contingent Consideration Payment
ContingentConsiderationPayment
36000 usd
CY2023Q4 us-gaap Goodwill Gross
GoodwillGross
5384000 usd
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-50000 usd
CY2024Q2 us-gaap Goodwill Gross
GoodwillGross
5334000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
8922000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-2383000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
6539000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
9006000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-2079000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
6927000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
540000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
495000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
572000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1109000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1104000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1070000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
696000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
1988000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
6539000 usd
CY2024Q2 us-gaap Restricted Stock Expense
RestrictedStockExpense
127000 usd
us-gaap Restricted Stock Expense
RestrictedStockExpense
275000 usd
CY2023Q2 us-gaap Restricted Stock Expense
RestrictedStockExpense
147000 usd
us-gaap Restricted Stock Expense
RestrictedStockExpense
148000 usd
CY2024Q2 vrme Stock Issued During Period Value Restricted Stock Award Net
StockIssuedDuringPeriodValueRestrictedStockAwardNet
69000 usd
vrme Stock Issued During Period Value Restricted Stock Award Net
StockIssuedDuringPeriodValueRestrictedStockAwardNet
333000 usd
CY2023Q2 vrme Stock Issued During Period Value Restricted Stock Award Net
StockIssuedDuringPeriodValueRestrictedStockAwardNet
149000 usd
vrme Stock Issued During Period Value Restricted Stock Award Net
StockIssuedDuringPeriodValueRestrictedStockAwardNet
412000 usd
us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
1750 shares
us-gaap Restricted Stock Shares Issued Net Of Shares For Tax Withholdings
RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings
38095 shares
CY2024Q1 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
30000 shares
CY2024Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
42000 usd
CY2024Q2 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
30000 shares
CY2024Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
42000 usd
CY2024Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
270367 shares
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
329351 shares
CY2024Q2 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
464000 usd
CY2023Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
659000 usd
CY2023Q4 us-gaap Accelerated Share Repurchases Adjustment To Recorded Amount
AcceleratedShareRepurchasesAdjustmentToRecordedAmount
500000 usd
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
1000 shares
CY2024Q2 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
1000 usd
CY2024Q2 vrme Unrecognized Compensation Cost Outstanding
UnrecognizedCompensationCostOutstanding
0 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
4628586 shares
CY2023Q4 vrme Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice
4.13
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
4628586 shares
CY2024Q2 vrme Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice
4.13
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
P1Y9M18D
CY2024Q2 vrme Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber
4628586 shares
CY2024Q2 vrme Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageExercisePrice
4.13
vrme Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Exercisable Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingExercisableWeightedAverageRemainingContractualTerms
P1Y9M18D
CY2024Q2 us-gaap Short Term Borrowings
ShortTermBorrowings
500000 usd
CY2024Q2 us-gaap Long Term Debt
LongTermDebt
600000 usd
vrme Principal Outstanding
PrincipalOutstanding
250000 usd
us-gaap Line Of Credit Facility Average Outstanding Amount
LineOfCreditFacilityAverageOutstandingAmount
0 usd
CY2022Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
1958000 usd
CY2022Q4 us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.07602 pure
CY2023Q3 us-gaap Debt Instrument Periodic Payment Principal
DebtInstrumentPeriodicPaymentPrincipal
1100000 usd
CY2023Q3 vrme Convertiable Promissory Notes Purchased By Related Party
ConvertiablePromissoryNotesPurchasedByRelatedParty
475000 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
44000 usd
CY2024Q2 us-gaap Convertible Debt
ConvertibleDebt
1100000 usd
CY2024Q2 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
0 usd
CY2023Q4 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
0 usd
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.21 pure
CY2024Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
48000 usd
CY2023Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
48000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
95000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
85000 usd
CY2024Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
4000 usd
CY2023Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
9000 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
9000 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
18000 usd
CY2024Q2 us-gaap Lease Cost
LeaseCost
52000 usd
CY2023Q2 us-gaap Lease Cost
LeaseCost
57000 usd
us-gaap Lease Cost
LeaseCost
104000 usd
us-gaap Lease Cost
LeaseCost
103000 usd
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
378000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
468000 usd
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
165000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
170000 usd
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
223000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
307000 usd
CY2024Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
388000 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
477000 usd
CY2024Q2 vrme Cash Paid For Amounts Included In Measurement Of Operating Lease Liabilities
CashPaidForAmountsIncludedInMeasurementOfOperatingLeaseLiabilities
94000 usd
CY2023Q4 vrme Cash Paid For Amounts Included In Measurement Of Operating Lease Liabilities
CashPaidForAmountsIncludedInMeasurementOfOperatingLeaseLiabilities
177000 usd
CY2024Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y8M12D
CY2024Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.064 pure
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
95000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
193000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
139000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
45000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
472000 usd
CY2024Q2 us-gaap Receivable With Imputed Interest Net Amount
ReceivableWithImputedInterestNetAmount
84000 usd
CY2024Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
388000 usd
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
165000 usd
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
223000 usd
CY2024Q2 us-gaap Revenues
Revenues
5352000 usd
CY2023Q2 us-gaap Revenues
Revenues
5335000 usd
us-gaap Revenues
Revenues
11111000 usd
us-gaap Revenues
Revenues
10996000 usd
CY2024Q2 us-gaap Gross Profit
GrossProfit
2090000 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
1586000 usd
us-gaap Gross Profit
GrossProfit
4350000 usd
us-gaap Gross Profit
GrossProfit
3107000 usd
CY2024Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
894000 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
836000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2015000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2249000 usd
CY2024Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5000 usd
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
60000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
18000 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-536000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1038000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1183000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-2542000 usd
CY2024Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
190000 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
156000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
284000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
80000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-346000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-882000 usd
us-gaap Net Income Loss
NetIncomeLoss
-899000 usd
us-gaap Net Income Loss
NetIncomeLoss
-2462000 usd

Files In Submission

Name View Source Status
0001214659-24-014333-index-headers.html Edgar Link pending
0001214659-24-014333-index.html Edgar Link pending
0001214659-24-014333.txt Edgar Link pending
0001214659-24-014333-xbrl.zip Edgar Link pending
ex10_2.htm Edgar Link pending
ex10_3.htm Edgar Link pending
ex31_1.htm Edgar Link pending
ex31_2.htm Edgar Link pending
ex32_1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
vrme-20240630.xsd Edgar Link pending
y8624010q.htm Edgar Link pending
vrme-20240630_def.xml Edgar Link unprocessable
vrme-20240630_pre.xml Edgar Link unprocessable
y8624010q_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable
vrme-20240630_cal.xml Edgar Link unprocessable
vrme-20240630_lab.xml Edgar Link unprocessable